International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1 doi: 10.5281/zenodo.10663227
Original Article
Assessing the Prevalence and Correlates of Peripheral Neuropathy in Type 2 Diabetes Patients A Cross-Sectional Study
 ,
Published
Feb. 14, 2024
Abstract

Background: Peripheral neuropathy is a prevalent and debilitating complication of Type 2 Diabetes Mellitus (T2DM), significantly affecting patients' quality of life. This study aimed to assess the prevalence and correlates of peripheral neuropathy among T2DM patients.

Methods: A cross-sectional study was conducted on 400 T2DM patients, assessing the presence of peripheral neuropathy and analyzing its association with demographic, clinical, and lifestyle factors.

Results: The prevalence of peripheral neuropathy was found to be 40%. Significant correlates of peripheral neuropathy included BMI ≥30 kg/m² (adjusted Odds Ratio [aOR]=1.8, p=0.02), duration of diabetes >10 years (aOR=2.3, p<0.01), and HbA1c >9% (aOR=2.9, p<0.01). Smoking showed a trend towards increased risk but was not statistically significant in the adjusted model.

Conclusion: Peripheral neuropathy affects a significant proportion of T2DM patients, with obesity, long duration of diabetes, and poor glycemic control being key associated factors. These findings highlight the critical need for integrated diabetes management strategies focusing on weight and glycemic control to prevent or delay the onset of peripheral neuropathy.

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
1823 Views
289 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved